Mifepristone antagonization requires real studies to evaluate safety and efficacy

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)427-429
Number of pages3
JournalContraception
Volume100
Issue number6
DOIs
StatePublished - Dec 2019

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Mifepristone antagonization requires real studies to evaluate safety and efficacy. / Creinin, Mitchell D.; Chen, Melissa J.

In: Contraception, Vol. 100, No. 6, 12.2019, p. 427-429.

Research output: Contribution to journalComment/debate

@article{ded1e11ce8e34e0ea4b31f298c63527d,
title = "Mifepristone antagonization requires real studies to evaluate safety and efficacy",
author = "Creinin, {Mitchell D.} and Chen, {Melissa J.}",
year = "2019",
month = "12",
doi = "10.1016/j.contraception.2019.10.016",
language = "English (US)",
volume = "100",
pages = "427--429",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Mifepristone antagonization requires real studies to evaluate safety and efficacy

AU - Creinin, Mitchell D.

AU - Chen, Melissa J.

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85075746896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075746896&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2019.10.016

DO - 10.1016/j.contraception.2019.10.016

M3 - Comment/debate

C2 - 31734073

AN - SCOPUS:85075746896

VL - 100

SP - 427

EP - 429

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 6

ER -